Stem Cell Biotech Neuroplast Enrolls First Patient in Phase II Clinical Trial of Transformative Neuro-Cells^® Treatment for Traumatic Spinal Cord Injury

Neuroplast has enrolled its first patient in a Phase II clinical trial to evaluate efficacy of its transformative Neuro-Cells® treatment that aims to prevent further damage to the central nervous system after sustaining acute traumatic spinal cord injury.